Related Experiment Video
Updated: Jun 18, 2025
06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
1.7K
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis
Sampson L Abu1, Navpreet K Hehar, DeGaulle I Chigbu
1Pennsylvania College of Optometry, Salus at Drexel University, Elkins Park, Pennsylvania, USA.
Current Opinion in Allergy and Clinical Immunology
|July 30, 2024
Summary
Novel therapies for allergic conjunctivitis target specific receptors, offering more effective and safer long-term treatment options beyond traditional antihistamines and corticosteroids.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Allergic conjunctivitis involves ocular surface inflammation driven by immune mediators.
- Current treatments like antihistamines and corticosteroids offer relief but have limitations for long-term use.
Purpose of the Study:
- To review novel agonist and antagonist therapies for allergic conjunctivitis.
- To explore treatments targeting glucocorticoid, melanocortin, toll-like, cytokine, chemokine, integrin, and histamine receptors.
Main Methods:
- Review of recent advancements in immunology and pharmacology.
- Focus on synthetic molecules and biologics interfering with allergic immune reactions.
Main Results:
- Significant progress in understanding allergic conjunctivitis mechanisms.
- Development of targeted therapies modulating specific receptor pathways.
Conclusions:
- Novel receptor-targeted therapies show promise for allergic conjunctivitis.
- These approaches may lead to improved efficacy and safety in managing allergic eye diseases.
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
712
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
712
01:30Adrenergic Agonists: Therapeutic Uses
759
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
759
01:30Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
01:27Open Angle Glaucoma: Treatment
420
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
420
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K